OncoSil Medical Limited (ASX:OSL)
Australia flag Australia · Delayed Price · Currency is AUD
0.6450
0.00 (0.00%)
Nov 17, 2026, 10:35 AM AEDT

OncoSil Medical Revenue

In the fiscal year ending June 30, 2026, OncoSil Medical had annual revenue of 5.09M AUD with 231.48% growth. OncoSil Medical had revenue of 1.91M in the half year ending June 30, 2026, with 107.00% growth. That makes OncoSil Medical the 41,130th largest company in the world by revenue and 804th in Australia.

Revenue
5.09M
Revenue Growth
+231.48%
P/S Ratio
4.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.67M

Revenue Chart

Revenue by Geography

  • Europe 1.40M 83.4%
  • Middle East 189.10K 11.2%
  • Australia 91.36K 5.4%
Fiscal year ended Jun 30, 2026 See the full OncoSil Medical breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20265.09M3.55M231.48%
Jun 30, 20251.54M-30.12K-1.92%
Jun 30, 20241.57M97.96K6.68%
Jun 30, 20231.47M404.03K38.00%
Jun 30, 20221.06M-234.94K-18.10%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Saluda Medical130.35M
Compumedics61.88M
Nova Eye Medical34.87M
CleanSpace Holdings19.82M
Micro-X15.09M
ImpediMed14.61M
CurveBeam AI8.67M
Control Bionics4.77M
Revenue Rankings